Prof. Dr. med. Markus Guba

About Prof. Dr. med. Markus Guba

Prof. Dr. med. Markus Guba, With an exceptional h-index of 46 and a recent h-index of 27 (since 2020), a distinguished researcher at Ludwig-Maximilians-Universität München, specializes in the field of Transplantation und Hepatobiliäre Chirurgie.

His recent articles reflect a diverse array of research interests and contributions to the field:

Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation–Long-term follow-up of a multicenter randomized controlled trial

Microbiome Dysbiosis with Enterococcus Presence in the Upper Gastrointestinal Tract is A Risk Factor for Mortality in Patients Undergoing Surgery for Pancreatic Cancer

Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: A meta-analysis

A long road ahead. A German national survey study on awareness and willingness of surgeons towards the carbon footprint of modern surgical procedures

Liver transplantation for treatment of nonresectable primary and secondary liver malignancies: Hepatocellular and cholangiocellular carcinomas and colorectal liver metastases

The outcome after liver transplantation may be affected by the circadian rhythm of liver transplant donors

Lebertransplantation in der Therapie nichtresektabler primärer und sekundärer Lebermalignome

Implications of peak-MELD-scores for the outcome of patients listed for liver transplantation

Prof. Dr. med. Markus Guba Information

University

Position

Chirurgische Klinik Klinikum Großhadern

Citations(all)

13461

Citations(since 2020)

4077

Cited By

10876

hIndex(all)

46

hIndex(since 2020)

27

i10Index(all)

121

i10Index(since 2020)

85

Email

University Profile Page

Ludwig-Maximilians-Universität München

Google Scholar

View Google Scholar Profile

Prof. Dr. med. Markus Guba Skills & Research Interests

Transplantation und Hepatobiliäre Chirurgie

Top articles of Prof. Dr. med. Markus Guba

Title

Journal

Author(s)

Publication Date

Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation–Long-term follow-up of a multicenter randomized controlled trial

Hepatology Communications

Zoltan Czigany

Deniz Uluk

Sandra Pavicevic

Isabella Lurje

Jiří Froněk

...

2024/2/1

Microbiome Dysbiosis with Enterococcus Presence in the Upper Gastrointestinal Tract is A Risk Factor for Mortality in Patients Undergoing Surgery for Pancreatic Cancer

Annals of Surgery

Christoph K Stein-Thoeringer

Bernhard W Renz

Juliana De Castilhos

Viktor von Ehrlich-Treuenstätt

Ulrich Wirth

...

2024/1/26

Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: A meta-analysis

Moritz Drefs

Markus B Schoenberg

Nikolaus Börner

Dionysios Koliogiannis

Dominik T Koch

...

2024/1/11

A long road ahead. A German national survey study on awareness and willingness of surgeons towards the carbon footprint of modern surgical procedures

Heliyon

Sven Jacob

Sophie Anne Schust

Martin Angele

Jens Werner

Markus Guba

...

2024/2/15

Liver transplantation for treatment of nonresectable primary and secondary liver malignancies: Hepatocellular and cholangiocellular carcinomas and colorectal liver metastases

Markus Guba

Jens Werner

2024/2/8

The outcome after liver transplantation may be affected by the circadian rhythm of liver transplant donors

Zeitschrift für Gastroenterologie

Mona-May Langer

Dionysios Koliogiannis

Christiane Paulig

Klaudja Ograja

Markus Guba

...

2024/1

Lebertransplantation in der Therapie nichtresektabler primärer und sekundärer Lebermalignome

Markus Guba

Jens Werner

2024/2/8

Implications of peak-MELD-scores for the outcome of patients listed for liver transplantation

Zeitschrift für Gastroenterologie

Paul Jamme

Dionysios Koliogiannis

Christiane Paulig

Klaudja Ograja

Markus Guba

...

2024/1

The role of microbiota in liver transplantation and liver transplantation-related biliary complications

Ulrich Wirth

Tianxiao Jiang

Josefine Schardey

Katharina Kratz

Mingming Li

...

2023/3/2

Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver Transplantation

Journal of Hepatocellular Carcinoma

Thi Phuong Thao Hoang

Philipp Schindler

Nikolaus Börner

Max Masthoff

Mirjam Gerwing

...

2023/12/31

Nachhaltigkeit im OP–korrelieren Sterilität, Sicherheit und Service auch mit einer ressourcenschonenden Verwendung von Medizinprodukten?

OP-Management up2date

Josef Egetemeyer

Sven Jacob

Ferdinand Lehmann

Markus Guba

Jens Werner

...

2023/9

Der Einfluss der Primär Sklerosierenden Cholangitis (PSC) und Sekundär Sklerosierenden Cholangitis (SSC) als Indikation zur Lebertransplantation auf das patientenindividuelle …

Zeitschrift für Gastroenterologie

M Drefs

LI-L Weiss

D Koliogiannis

FMJ Ilmer

DT Koch

...

2023/8

Projekt:„zero emission surgery “

Sven Jacob

Jan Brinke

Markus Schoenberg

Martin Angele

Markus Guba

...

2023/3

Baseline Interleukin-6 as a Preoperative Biomarker for Liver Fibrosis

Visceral Medicine

Dominik Thomas Koch

Dionysios Koliogiannis

Moritz Drefs

Malte Schirren

Viktor von Ehrlich-Treuenstätt

...

2023/12/28

Celiac trunk stenosis may be a cofactor for the development of acute liver failure

Zeitschrift für Gastroenterologie

B Feuerecker

M Wildgruber

M Schirren

R Schinner

C Lange

...

2023/8

Liver Resection for Perihilar Cholangiocarcinoma: Finding a Balance between Perioperative mortality and Oncologic benefit

Zeitschrift für Gastroenterologie

E Payani

D Koliogiannis

M Schirren

H Niess

M Angele

...

2023/8

Auxilliary liver transplantation according to the RAPID procedure in noncirrhotic patients: technical aspects and early outcomes

Annals of Surgery

Utz Settmacher

Aladdin Ali-Deeb

Laurent Coubeau

Umberto Cillo

Pål-Dag Line

...

2023/2/1

Dysbiose des Mikrobioms im oberen Gastrointestinaltrakt ist ein Risikofaktor für die Mortalität von Patienten nach Pankreaskopfoperationen

Zeitschrift für Gastroenterologie

M Ilmer

CK Stein-Thöringer

BW Renz

J De Castilhos

V von Ehrlich-Treuenstätt

...

2023/8

Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells

Journal of Translational Medicine

Dominik T Koch

Haochen Yu

Iris Beirith

Malte Schirren

Moritz Drefs

...

2023/12/2

Regional transplant rates depend more on physician-dependent variables than on proximity to transplant center

Langenbeck's Archives of Surgery

Elnaz Payani

Nikolaus Börner

Dionysios Kolliogiannis

Stefan Brunner

Ingo Klein

...

2023/5/12

See List of Professors in Prof. Dr. med. Markus Guba University(Ludwig-Maximilians-Universität München)